MariMed seeks shareholder approval for 1-for-50 to 1-for-100 reverse stock split

• MariMed filed a definitive proxy to seek stockholder authorization for a reverse stock split to support a potential U.S. exchange listing.
• Board would have discretion to execute a 1-for-50 to 1-for-100 share consolidation, or not proceed.
• Virtual special meeting set for Oct. 28, 2026; record date is Sept. 4, 2026.
• No fractional shares; holders would receive cash in lieu.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marimed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609230700PRIMZONEFULLFEED9831807) on September 23, 2026, and is solely responsible for the information contained therein.